Spun out of the University of Arkansas at Little Rock, NuShores Biosciences is organized around developing and commercializing bone and tissue regeneration technologies. Headed up by a long time experienced expert in effective SBIR participation, the firm has the exclusive, global license from UA Little Rock to commercialize university-owned patented and patent-pending technologies related to the NuCress™ scaffold: a nanomaterial-based bone regeneration device developed for large segmental defects. Nushores offers NuCress products for healing large segmental bone defects and solutions to various bone regeneration needs for cranio-maxillofacial, dental, limbs, or spine. The particular focus to date of the firm's SBIR efforts in this space are in the dental space.
